Gonadorelin
- Generic Name
- Gonadorelin
- Brand Names
- Lutrepulse
- Drug Type
- Small Molecule
- Chemical Formula
- C55H75N17O13
- CAS Number
- 33515-09-2
- Unique Ingredient Identifier
- 9O7312W37G
- Background
Gonadorelin is another name for gonadotropin-releasing hormone (GnRH). It is a synthetic decapeptide prepared using solid phase peptide synthesis. GnRH is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pituitary.
- Indication
For evaluating the functional capacity and response of the gonadotropes of the anterior pituitary also for evaluating residual gonadotropic function of the pituitary following removal of a pituitary tumor by surgery and/or irradiation.
- Associated Therapies
- Ovulation induction therapy
Luteal Phase Ovarian Stimulation With Follitropin Delta and Dydrogesterone
- Conditions
- Oocyte DonationOocyte Donors
- Interventions
- First Posted Date
- 2022-08-30
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- CRG UZ Brussel
- Target Recruit Count
- 50
- Registration Number
- NCT05521828
- Locations
- 🇧🇪
Brussels Ivf, Brüssel, Belgium
GnRH Agonist for Luteal Phase Support.
- Conditions
- Use of GnRH Agonist Alone for Luteal Phase Support in Fresh IVF Cycles
- Interventions
- First Posted Date
- 2022-08-02
- Last Posted Date
- 2022-08-02
- Lead Sponsor
- Shaare Zedek Medical Center
- Target Recruit Count
- 150
- Registration Number
- NCT05484193
- Locations
- 🇮🇱
Shaare Zedek medical Center, Jerusalem, Israel
Effect of GH on the Blastocyst Euploid Rate in AMA Patients
- Conditions
- Age, ParentalPreimplantation Genetic TestingGrowth Hormone
- Interventions
- First Posted Date
- 2022-07-07
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- ShangHai Ji Ai Genetics & IVF Institute
- Target Recruit Count
- 400
- Registration Number
- NCT05447208
- Locations
- 🇨🇳
Shanghai JIAI Genetics and IVF Institute, Shanghai, Shanghai, China
Effects of Co-treatment on Endometrial abv3-integrin Expressions in Women With Recurrent Implantation Failure
- Conditions
- Miscarriage, Recurrent
- Interventions
- First Posted Date
- 2022-06-29
- Last Posted Date
- 2022-06-29
- Lead Sponsor
- Universiti Kebangsaan Malaysia Medical Centre
- Target Recruit Count
- 39
- Registration Number
- NCT05437471
- Locations
- 🇲🇾
UniversitiKMMC, Kuala Lumpur, Malaysia
Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A
- Conditions
- Preimplantation Genetic TestingProgestin-primed Ovarian StimulationPolycystic Ovarian SyndromeGnRH Antagonist
- Interventions
- First Posted Date
- 2022-04-13
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- ShangHai Ji Ai Genetics & IVF Institute
- Target Recruit Count
- 204
- Registration Number
- NCT05326087
Efficacy of Prolonged GnRH Test in Male Adolescents With Postoperative HH
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT05184374
- Locations
- 🇨🇳
Huashan Hospital, Shanghai, Shanghai, China
Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study)
- Conditions
- MenopauseEstrogen DeficiencyWomenAging
- Interventions
- First Posted Date
- 2021-09-27
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 55
- Registration Number
- NCT05057546
- Locations
- 🇺🇸
University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, United States
Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism
- Conditions
- Hypogonadotropic Hypogonadism
- Interventions
- First Posted Date
- 2020-12-02
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- Stephanie B. Seminara, MD
- Target Recruit Count
- 24
- Registration Number
- NCT04648969
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response
- Conditions
- IVFGnRH AntagonistPPOS
- Interventions
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- ShangHai Ji Ai Genetics & IVF Institute
- Target Recruit Count
- 784
- Registration Number
- NCT04414761
- Locations
- 🇨🇳
ShangHai JIAI Genetics&IVF Institute, Shanghai, China
Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Patients Undergoing PGT-A
- Conditions
- Progestin-primed Ovarian StimulationGnRH AntagonistPreimplantation Genetic TestingEuploid Rate
- Interventions
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- ShangHai Ji Ai Genetics & IVF Institute
- Target Recruit Count
- 400
- Registration Number
- NCT04414748
- Locations
- 🇨🇳
Shanghai JiAi Genetics & IVF Institute, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.